Literature DB >> 2585231

Spontaneous tumor necrosis factor production in Kawasaki disease.

B A Lang1, E D Silverman, R M Laxer, A S Lau.   

Abstract

Tumor necrosis factor production by peripheral blood mononuclear cells was measured in 18 patients with Kawasaki disease. In patients studied during the acute febrile phase of their disease, there was increased spontaneous TNF production (mean 26.9 +/- 40.3 U/ml) compared with that of control subjects (1.0 +/- .86 U/ml) (p less than or equal to 0.025). Spontaneous TNF production by patients tested in the subacute or convalescent phase of the illness was significantly lower than that in patients tested during the acute illness (p less than or equal to 0.025). In all patients studied with serial acute and subacute-convalescent samples, TNF production was normal in the follow-up samples. Because TNF is a potent mediator of inflammation and causes damage to vascular endothelial cells, we suggest that TNF may be important in the pathogenesis of both the immune activation and endothelial cell damage characteristic of this illness.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2585231     DOI: 10.1016/s0022-3476(89)80746-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

Review 1.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.

Authors:  D Y Leung
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 2.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 3.  Superantigens related to Kawasaki syndrome.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease.

Authors:  H Suzuki; S Uemura; S Tone; T Iizuka; M Koike; K Hirayama; J Maeda
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

Review 5.  The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases.

Authors:  H Senzaki
Journal:  Arch Dis Child       Date:  2006-10       Impact factor: 3.791

6.  Serum resistin concentrations in children with Kawasaki disease.

Authors:  Hiroki Nozue; Hironori Imai; Hisako Saitoh; Takeshi Aoki; Kunio Ichikawa; Tomohiro Kamoda
Journal:  Inflamm Res       Date:  2010-04-27       Impact factor: 4.575

7.  Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis.

Authors:  N Kumar Tripathy; S Kumar Chauhan; S Nityanand
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

8.  Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells.

Authors:  M Sakaguchi; H Kato; A Nishiyori; K Sagawa; K Itoh
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

9.  Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.

Authors:  J Abe; B L Kotzin; K Jujo; M E Melish; M P Glode; T Kohsaka; D Y Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies.

Authors:  E Grunebaum; M Blank; S Cohen; A Afek; J Kopolovic; P L Meroni; P Youinou; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.